National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 9368 [2019-04664]

Download as PDF 9368 Federal Register / Vol. 84, No. 50 / Thursday, March 14, 2019 / Notices limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: March 11, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–04758 Filed 3–13–19; 8:45 am] BILLING CODE 4140–01–P Agenda: To review and evaluate contract proposals. Place: Hyatt Regency Bethesda. One Bethesda Metro Center. 7400 Wisconsin Avenue. Bethesda, MD 20814. Contact Person: Eleazar Cohen, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room 3G62A, National Institute of Health, NIAID, 5601 Fishers Lane, MSC 9823, Bethesda, MD 20899823, (240) 669–5081, ecohen@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS). Dated: March 8, 2019. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health [FR Doc. 2019–04664 Filed 3–13–19; 8:45 am] National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases, Special Emphasis Panel; NIAID Omnibus BAA, (HHS–NIH–NIAID–BAA2018), Research Area 003: Collaborative Influenza Vaccine Innovation Centers (CIVIC): Component C— Clinical Core. Date: April 5, 2019. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Lee G Klinkenberg, Ph.D., Scientific Review Program, DEA/NIAID/NIH/ DHHS, 5601 Fishers Lane, MSC–9823 Bethesda, MD 20892–9834, 301–761–7749, lee.klinkenberg@nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Omnibus BAA (HHS–NIH–NIAID–BAA2018), Research Area 003: Collaborative Influenza Vaccine Innovation Centers (CIVIC) (N01); Component A. Time: April 11–12, 2019. Time: 9:00 a.m. to 5:00 p.m. VerDate Sep<11>2014 17:22 Mar 13, 2019 Jkt 247001 BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Omnibus BAA (HHS–NIH–NIAID–BAA2018) Research Area 003: Collaborative Influenza Vaccine Innovation Centers (CIVIC) (N01); Component B. Date: April 4, 2019. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Eleazar Cohen, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room 3G62A, National Institute of Health, NIAID, 5601 Fishers Lane, MSC 9823, PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 Bethesda, MD 20899823, (240) 669–5081, ecohen@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS). Dated: March 8, 2019. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–04663 Filed 3–13–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; AD & RELATED DEMENTIAS—II [2019/10 ZAG1 ZIJ–P (O2))]. Date: April 3, 2019. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, Suite 2W200, 7201 Wisconsin Avenue, Bethesda, MD 20892. Contact Person: Nijaguna Prasad, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Aging, 7201 Wisconsin Avenue, Gateway Building, Suite 2W200, Bethesda, MD 20892, 301–496–9667, nijaguna.prasad@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: March 11, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–04751 Filed 3–13–19; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\14MRN1.SGM 14MRN1

Agencies

[Federal Register Volume 84, Number 50 (Thursday, March 14, 2019)]
[Notices]
[Page 9368]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-04664]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases, Special Emphasis Panel; NIAID Omnibus BAA, (HHS-NIH-NIAID-
BAA2018), Research Area 003: Collaborative Influenza Vaccine 
Innovation Centers (CIVIC): Component C--Clinical Core.
    Date: April 5, 2019.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Lee G Klinkenberg, Ph.D., Scientific Review 
Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, MSC-9823 Bethesda, 
MD 20892-9834, 301-761-7749, lee.klinkenberg@nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Omnibus BAA (HHS-NIH-NIAID-
BAA2018), Research Area 003: Collaborative Influenza Vaccine 
Innovation Centers (CIVIC) (N01); Component A.
    Time: April 11-12, 2019.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Hyatt Regency Bethesda. One Bethesda Metro Center. 7400 
Wisconsin Avenue. Bethesda, MD 20814.
    Contact Person: Eleazar Cohen, Ph.D., Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, Room 
3G62A, National Institute of Health, NIAID, 5601 Fishers Lane, MSC 
9823, Bethesda, MD 20899823, (240) 669-5081, ecohen@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS).

    Dated: March 8, 2019.
Natasha M. Copeland,
 Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-04664 Filed 3-13-19; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.